Neil Woodford’s High Income Fund Farewell: Wm. Morrison Supermarkets plc, Rentokil Initial plc And Sanofi SA

Woodford’s mega-million moves on Wm. Morrison Supermarkets plc (LON:MRW), Rentokil Initial plc (LON:RTO) and Sanofi SA (NYSE:SNY).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Neil Woodford announced last October that he was calling time on his quarter-century career with asset management group Invesco Perpetual. Britain’s most celebrated money manager handed over control of his Invesco funds last month, and will shortly launch his own equity income vehicle from his new Woodford Investment Management business.

Invesco has just published the final annual report under Woodford’s tenure of the £13.5bn flagship High Income fund. The report reveals some of the City wizard’s last mega-million moves for the fund, including big trades in Wm. Morrison Supermarkets (LSE: MRW)Rentokil Initial (LSE: RTO) and Sanofi (NYSE: SNY.US).

Inflation Is Coming

Inflation is out of control, and people are running scared. But right now there’s one thing we believe Investors should avoid doing at all costs… and that’s doing nothing. That’s why we’ve put together a special report that uncovers 3 of our top UK and US share ideas to try and best hedge against inflation… and better still, we’re giving it away completely FREE today!

Click here to claim your copy now!

Woodford’s share buys and sells during the first half of the year were balanced. However, the second half of the year saw net sales of around £1bn, as Woodford paid out to investors who pulled out of the fund after the announcement of his departure.

We saw a trimming of many holdings to raise the £1bn, but there were also some large positions that Woodford exited completely.

Wm. Morrison Supermarkets

Woodford disposed of the High Income fund’s 68.4 million shares in Morrisons, raising a whopping £187m. The numbers give a sale price of about 273p a share. Whether Woodford had become disillusioned with his former supermarket favourite, or was getting shot of a company his successor wasn’t keen on, is a moot point.

Either way, it was a timely sale, as the shares are currently trading at not much more than 200p — representing 14 times forecast earnings with a potential income of 6.5%.

It will be interesting to see whether Woodford buys back into Morrisons for his new fund. I see the supermarket as being in a similar position to AstraZeneca a couple of years ago, when the contrarian Woodford was piling into the then-unloved pharmaceuticals firm.

Rentokil Initial

Rentokil, which has a wider range of hygiene businesses than the soubriquet ‘royal rat catcher’ suggests, is another holding Woodford has binned. The sale of the High Income fund’s substantial stake in the mid-cap firm raised £117m. My sums say Woodford sold at about 105p a share, compared with 116p today.

Like Morrisons, Rentokil trades on a forward P/E of 14, but the prospective dividend yield is much lower at 2.2%. Woodford originally bought into Rentokil as “a significant restructuring opportunity”. The bulk of the restructuring has been done, and it remains to be seen whether Woodford thinks the story has further to run and buys back into Rentokil for his new fund.

Sanofi

Given the outflow of money from the High Income fund, and the net £1bn of share sales to cover the redemptions, I was surprised to find Woodford actually increasing the fund’s stake in some companies.

Woodford added modestly to a few of his Footsie favourites, including Imperial Tobacco, GlaxoSmithKline and Centrica, but substantially upped the fund’s stake in French drugs giant Sanofi. He increased the holding by almost 50% during the course of the year, spending in the region of £100m.

The Paris-listed company, which can also be traded on the New York stock exchange, is on a forward P/E of 14 — the same as FTSE counterpart GlaxoSmithKline. Analysts have Sanofi delivering faster earnings growth over the next couple of years, but GlaxoSmithKline offering a higher dividend.

More on Investing Articles

Social media and digital online concept, woman using smartphone
Investing Articles

Will Lloyds shares recover in 2022?

Lloyds shares have struggled this year and the looming recession won't help. But I'd still buy them today.

Read more »

Two hands holding champagne glasses toasting each other with Paris in the background
Investing Articles

Can the stock market make me rich even now?

Here are three ways I'm coping with the stock market's recent bout of weakness and aiming to build wealth in…

Read more »

Cogs turning against each other
Investing Articles

3 top investment trusts to buy right now

Investment trusts offer a wide range of options for investors. And in troubled times, they provide some safety through diversification…

Read more »

pensive bearded business man sitting on chair looking out of the window
Investing Articles

Why hasn’t the FTSE 100 crashed in 2022?

The catastrophic events of 2022 have left investors around the globe fearing the worst for stock markets. And some have…

Read more »

Trader on video call from his home office
Investing Articles

2 inflation-resistant FTSE 100 stocks to buy today

Soaring inflation could dent my returns if I don't take care. Here are two top inflation-resistant FTSE 100 stocks I'd…

Read more »

Tabletop model of a bear sat on desk in front of monitors showing stock charts
Investing Articles

Why a bear market is an investor’s best friend

A bear market can certainly be scary. But any investor tempted to sell might benefit by looking at Warren Buffett's…

Read more »

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

The Rolls-Royce share price could be stuck below £1 for a while. Should I buy?

The Rolls-Royce share price has been trading at penny stock levels since April. Could the stock be a bargain at…

Read more »

Young brown woman delighted with what she sees on her screen
Investing Articles

I’m aiming to make £45,000 in passive income with UK shares and never work again!

Investing regularly in UK shares can generate a substantial passive income over the long run. Zaven Boyrazian demonstrates how.

Read more »